25
Jun
2024

Public Webinar: Can Endpoints from Digital Technology Provide Meaningful Outcomes for HTA?

On 25 June 2024, RWE4Decisions hosted a webinar titled “Can endpoints from digital technology provide meaningful outcomes for Health Technology Assessment (HTA)?”

At the webinar, speakers discussed how patient-generated health data could be analyzed to support Health Technology Assessment (HTA) bodies and Payers, delving into issues such as app governance models, the use of AI, and more.


PROGRAMME

15:00

Welcome from the co-moderators

  • Eric Sutherland
    Senior Health Economist, OECD
    Bio
    Alina Pavel
    RWE4Decisions Secretariat
15:05

Presentations

  • Strategies for Development, Governance, and Assessment of Digital Health Technologies at Hospital Level
    Rossella di Bidino
    Head of the HTA for AI Unit, ALTEMS Università Cattolica; Co-Chair HTAi HB-HTA Interest Group
    Bio
  • Patient-controlled information flows and HTA in the global cystic fibrosis community
    Andreas Hager
    Board Member, Cystic Fibrosis Europe
    Bio
15:30

Panel discussion

  • Anja Schiel
    Senior Advisor, Methodologist in Regulatory and Pharmacoeconomic Statistics, Norwegian Medicinal Products Agency (NOMA)
    Bio
  • Lara Wolfson
    Associate Vice-President & Head HTA Statistics, MSD; Co-Chair, PSI/EFPSI HTA Special Interest Group
    Bio
16:05

Q&A with audience

16:25

Next steps

16:30

Meeting close